Search for Circulating Immune Complexes and Activation of the Complement System in Relation to Estrogen Treatment

References

• Beaumont V, Lemort N, Lorenzelli L, Mosser A, Beaumont J-L. Hormones contraceptives, risque vasculaire et prkcipitabilitk anormales des gammaglobulines skriques. Pathol Biol (Paris) 1978; 26: 531–7
   Google Scholar
• Beaumont V, Lemort N, Abbou C C, Beaumont J-L. Ethinylestradiol and diethylstilbestrol induced antibodies and vascular thrombosis. Biomedicine 1980; 32: 26–31
   Google Scholar
• Beaumont V, Delplanque B, Lemort N, Beaumont J-L. Blood changes in sex steroid hormone users. Circulating immune complexes induced by estrogens and progesterones and their relation to vascular thrombosis. Atherosclerosis 1982; 44: 343–53
   Google Scholar
• Plowright C, Adam S A, Thorogood M, Beaumont V, Beaumont J-L, Mann J I. Immunogenicity and the vascular risk of oral contraceptives. Br Heart J 1985; 53: 556–61
   Google Scholar
• Beaumont J-L, Lemort N, Lorenzelli-Edouard L, Delplanque B, Beaumont V. Antiethinyloestradiol antibody activities in oral contraceptive users. Clin Exp Immunol 1979; 38: 445–52
   PubMed Web of Science ®Google Scholar
• Beaumont V, Lemort N, Beaumont J-L. Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis. Am J Reprod Immunol 1982; 2: 8–12
   Web of Science ®Google Scholar
• WHO Scientific Group. The role of immune complexes in disease. Technical Series 606. WHO, Geneva 1977; 5–58
   Google Scholar
• Theofilopoulos A N, Dixon F J. The biology and detection of immune complexes. Adv Immunology 1979; 28: 89–220
   PubMedGoogle Scholar
• Theofilopoulos A N, Dixon F J. Immune complexes in human diseases. Am J Pathol 1980; 100(no. 2)531–91
   Google Scholar
• Julkunen I, Lindstrøm P, Wager O, Penttinen K. Immune complex assays and stored normal human sera. J Immunol Meth 1983; 56: 167–74
   Google Scholar
• Heimer R, Per S. Pitfalls in the methodology for detection of immune complexes. Surv Immunol Res 1982; 1: 109–16
   Google Scholar
• Farrell C, Bloth B, Nielsen H, Daugharty H, Lundman T, Svehag S-E. A survey for circulating immune complexes in patients with acute myocardial infarction. Use of a Clq–binding assay with soluble protein A as indicator. Scand J Immunol 1977; 61233–40
   Google Scholar
• Linnet L, Møller N PH, Bernth-Petersen P, Ehlers N, Brandslund I., Svehag S-E. No increase in arterioloscle-rotic retinopathy or activity in tests for circulating immune complexes 5 years after vasectomy. Fertil Steril 1982; 37: 798–806
   Google Scholar
• Yonemasu K, Stroud R B. Clq: Rapid purification method for preparation of monospecific antisera and for biochemical studies. J Immunol 1971; 106: 304–13
   PubMedGoogle Scholar
• Hunter W M, Greenwood F C. Preparation of Iodine 131-labelled human growth hormone of high specific activity. Nature 1962; 194: 495–6
   PubMed Web of Science ®Google Scholar
• Brandslund I, Siersted H C, Svehag S-E, Teisner B. Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J Immunol Methods 1981; 44: 63–71
   PubMed Web of Science ®Google Scholar
• Glikmann G, Svehag S-E, Nielsen H. A solid-phase, polyclonal IgM-RF binding assay for circulating immune complexes. Acta Pathol Microbiol Scand 1979; 87: 121–9
   Google Scholar
• Collins D C, Bain R P, Coan P, Macpherson R FC, Blumenstein B, Hall W D. Presence of the “Beaumont” protein in serum of oral contraceptive users. Fertil Steril 1983; 40: 490–6
   PubMed Web of Science ®Google Scholar
• Syner F N, Moghissi K S, Agronow S J. Study on the presence of abnormal proteins in the serum of oral contraceptive users. Fertil Steril 1983; 40: 202–09
   Google Scholar
• Huang N H, Li C, Goldzieher J W. Absence of antibodies to ethinyl estradiol in users of oral contraceptive steroids. Fertil Steril 1984; 41: 587–92
   Google Scholar
• Peterman B, Brandt M., Elendt D, Malberg K. Effect of oral contraceptives on circulating immune complexes. Zlbl Gynäkol 1982; 104: 349–53
   Google Scholar
• Laurell C-B, Kullander S, Thorell J. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins. Scand J Clin Lab Invest 1968; 21: 337–43
   PubMed Web of Science ®Google Scholar
• Ramcharan S, Sponzilli E E, Wingerd J C. Serum protein fractions. Effect of oral contraceptives and pregnancy. Obstetr Gynecol 1976; 48: 211–15
   Google Scholar